Health Products

Archived - Xiaokeshuping Jiangtangning Jiaonang

· Published by Health Canada · Official notice

Details

Alert type: Foreign Product Alert (FPA)
Category: Drugs
Issue: Product Safety, Undeclared Substance
Audience: General Public
Department: Health Canada
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Images

Details

These products are not authorized for sale in Canada and have not been found in the Canadian marketplace, but it is possible they may have been brought into the country by travellers or purchased over the Internet.

Source of alert

Hong Kong Department of Health

Product name

Xiaokeshuping Jiangtangning Jiaonang

Manufacturer / Place of origin

China

Product description

Xiaokeshuping Jiangtangning Jiaonang capsules are red-and-white in colour. The capsules are contained in a foil package within in a white-and-green box bearing Chinese lettering.

Reason for warning

The Hong Kong Department of Health (HKDH) found Xiaokeshuping Jiangtangning Jiaonang capsules to contain the undeclared pharmaceutical drugs phenformin, rosiglitazone, and glibenclamide, which may be used in diabetes to lower blood sugar. The HKDH conducted the analysis following receipt of a report that one woman in China had been hospitalized due to a serious hypoglycaemic attack (very low blood sugar) after using Xiaokeshuping Jiangtangning Jiaonang.

Phenformin was previously used for the treatment of diabetes, but was removed from the Canadian market in 1977 and banned in several countries, including Hong Kong, Singapore, Germany, France and the U.S.

Rosiglitazone and glibenclamide are used to lower blood glucose in the treatment of diabetes. These prescription drugs should only be used under the supervision of a healthcare professional

Phenformin, rosiglitazone, and glibenclamide may cause hypoglycemia (low blood sugar), particularly when combined with other blood glucose-lowering substances.

Possible side effects

Diabetic patients using other oral anti-diabetic medications in addition to Xiaokeshuping Jiangtangning Jiaonang could suffer serious side effects, including serious, life-threatening hypoglycemia.

Symptoms of hypoglycemia may include sweating, nausea, and trembling, which may lead to headaches and blurred vision. In severe cases, hypoglycemia may cause seizures and coma.

What you should do

Canadians who have this product are advised not to use it, and should consult with a health care professional if they have concerns about their health related to the use of this product.

Health Canada advises Canadians to contact the Health Products and Food Branch Inspectorate at 1-800-267-9675 if they find the product listed above in the Canadian marketplace.

Background

Drugs and natural health products that are authorized for sale in Canada will have either an eight-digit Drug Identification Number (DIN), a Natural Product Number (NPN) or a Homeopathic Medicine Number (DIN-HM) on the label. These numbers indicate that the products have been assessed by Health Canada for safety, effectiveness and quality.

As of the date of this posting, no adverse reactions suspected to be associated with the use of this product have been reported in Canada.

Report a health or safety concern

  • Call toll-free at 1-866-234-2345.
  • Visit Health Canada's Web page on Adverse Reaction Reporting for information on how to report online, by mail or by fax.

Media enquiries

Health Canada
613-957-2983

Public enquiries

613-957-2991
1-866-225-0709
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime